RxDoctor Payments Data

David Patton, MD

Obstetrics & Gynecology · Charleston, WVNPI 1730289513

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Intuitive Surgical at 47.4% of the total. Reporting peaked in 2020 at $4,847 and has fallen 79.5% since, to $992 in 2025. Among obstetrics & gynecology clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,869in general payments, 2019–2025

Across 286 payments — averaging $41.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$6K
  • Axonics, Inc.$2K
  • AbbVie$1K
  • Astellas Pharma US Inc$389
  • Shield Therapeutics Inc$375
  • Sage Therapeutics, LLC$351
  • plus $2K from 22 others

What the payments were for

  • Speaking & faculty fees$2552%
  • Travel & lodging$2,56222%
  • Food & beverage$5,87349%
  • Education$3,15627%
  • Gifts$230%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,869 in reported general payments places this provider in the 90th percentile of 172 obstetrics & gynecology providers in West Virginia.

See all obstetrics & gynecology providers in West Virginia

Medicare billing

Part B allowed, 2024
$39,706
Medicare patients
166
Services billed
370

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated16$5,176
Tolterodine Tartrate ErTolterodine Tartrate26$1,052
Estradiol36$882
MicrogestinNorethindrone Ac/Eth Estradiol13$276
Testosterone Cypionate11$250
Clobetasol Propionate15$185
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl12$171
Oxybutynin Chloride ErOxybutynin Chloride20$153

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$276$5,17616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 172 obstetrics & gynecology providers in West Virginia.

Other obstetrics & gynecology in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →